Back
Valneva SE 10K Form
Sell
31
INRLF
Valneva SE
Last Price:
$4.20
Seasonality Move:
7.26%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INRLF News And Ratings
See the #1 stock for the next 7 days that we like better than INRLF
INRLF Financial Statistics
Sales & Book Value
| Annual Sales: | $183.4M |
|---|---|
| Cash Flow: | $-26.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.03 |
| Price / Book: | 4.08 |
Profitability
| EPS (TTM): | -0.68540 |
|---|---|
| Net Income (TTM): | $-114.1M |
| Gross Margin: | $68.8M |
| Return on Equity: | -56.21% |
| Return on Assets: | -21.08% |
Valneva SE Earnings Forecast
Key Valneva SE Financial Ratios
-
The Gross Profit Margin over the past 20 years for INRLF is 37.53%.
-
The Selling, General & Administrative Expenses for INRLF have been equal to 56.08% of Gross Profit Margin.
-
The Research & Development expenses have been 40.01% of Revenue.
-
The Net Earning history of INRLF is -7.22% of Total Revenues.
-
Per Share Earnings over the last 20 years have been positive in 9 years.
Valneva SE Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | INRLF |
| Website: | valneva.com |
Debt
| Debt-to-Equity Ratio: | 1.3 |
|---|---|
| Current Ratio: | 1.78 |
| Quick Ratio: | 1.09 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
INRLF Technical Analysis vs Fundamental Analysis
Sell
31
Valneva SE (INRLF)
is a Sell
Is Valneva SE a Buy or a Sell?
-
Valneva SE stock is rated a SellThe current Valneva SE [INRLF] share price is $4.20. The Score for INRLF is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.